GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
0.67
0.03 (4.92%)
At close: Oct 06, 2025, 1:54 PM
GT Biopharma Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for GTBP stock have an median target of 11, with a low estimate of 11 and a high estimate of 11. The median target predicts an increase of 1541.79% from the current stock price of 0.67.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 11 | 11 | 11 | 11 |
| Change | 1541.79% | 1541.79% | 1541.79% | 1541.79% |
Latest Analyst Insight Report
According to 1 stock analyst, the rating for GT Biopharma Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Dec 24 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Financial Forecast this Year
Revenue This Year
13.5M
from 0
Increased by n/a%
Revenue Next Year
9.7M
from 13.5M
Increased by -28.1%
EPS This Year
-1.31
from -6.94
Increased by 81.1%
EPS Next Year
-0.62
from -1.31
Increased by 52.7%